TriangleFOR PATIENTS · SOURCE READING
High-dose 131I-MIBG therapy
Source: Childhood Pheochromocytoma and Paraganglioma Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: July 21, 2022 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview / Four types of standard treatment are used:
131I-MIBG therapy is a treatment with high-dose radioactive iodine. The radioactive iodine is given through an intravenous (IV) line and enters the bloodstream which carries radiation directly to tumor cells. Radioactive iodine collects in pheochromocytoma and paraganglioma cells and kills them with the radiation that is given off.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice